Trials / Completed
CompletedNCT01599611
Follow-up of Extreme Neonatal Hyperbilirubinemia in 5-10 Year Old Children: a Danish Population Based Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 128 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 5 Years – 10 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study was to investigate whether infants with total serum bilirubin \> 450 umol/L in the neonatal period and no symptoms or no more than early acute bilirubin encephalopathy develop long term sequelae with impairment of motor development, hearing and executive function compared with a control group.
Detailed description
Children in both the exposed and the non-exposed group were examined by use of the MABC-2 and pure tone audiometry by the responsible examiner for the study, Pernille Vandborg, MD. The aim was to see whether the exposed group suffered any long term sequelae to the extreme neonatal hyperbilirubinemia, i.e. impaired motor development or hearing impairment, compared to a control group. The examinations took place at the local hospital.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Movement assessment battery for children - 2 | A standardised test developed to identify developmental difficulties in children. |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2012-05-16
- Last updated
- 2012-05-16
Source: ClinicalTrials.gov record NCT01599611. Inclusion in this directory is not an endorsement.